- completed
A feasibility trial to assess recruitment rates and ctDNA reporting times for patients with resected stage IIB/IIC/IIIA melanoma
This UK study is looking at whether a regular blood test can safely check if melanoma (skin cancer) has returned after surgery. Instead of giving everyone preventive cancer drugs, doctors want to see if testing for cancer DNA can pinpoint only the people who truly need further treatment.
United Kingdom · England - recruitingNA
Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors
This study is testing a new way to treat skin cancer called DaRT. It uses tiny radioactive seeds placed directly into the tumour. The aim is to see if it's safe and helps shrink different types of skin cancer.
France - not yet recruitingPHASE3
iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma
This study looks at a new vaccine, iSCIB1+, for advanced skin cancer (melanoma). It wants to see if adding iSCIB1+ to standard immunotherapy (Nivolumab and Ipilimumab) helps people live longer and improves their health. Participants will get either the vaccine or a dummy treatment.
United States · United Kingdom - recruiting
Electroporation for Cancer Treatment Real World Registry
This study looks at how well a treatment called electroporation works for skin and gut cancers in everyday life. It checks how often tumours shrink, if they come back, and any side effects people experience. It helps understand the long-term effects of this treatment.
United Kingdom - recruitingPHASE2
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
This study looks at a medicine called atezolizumab for different cancers. We want to see if a special test of your cancer cells can predict if the medicine will work well for you. This helps us learn more about tailoring treatments.
Canada - not yet recruiting
Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis.
This study is looking for better ways to spot skin cancer early, especially in people with fair skin. Researchers are using different light technologies to examine skin and build a detailed database to improve diagnosis.
France - recruitingNA
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
This study looks at adding special radiation to standard care for rare cancers that have spread a little. It wants to see if this addition helps people live longer compared to standard care alone.
Belgium · France · Germany